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Does Ultrasound-Guided Directional
Vacuum-Assisted Removal Help Eliminate
Abnormal Nipple Discharge in Patients
with Benign Intraductal Single Mass? 
Objective: To evaluate whether the removal of an intraductal mass using an
ultrasound (US)-guided directional vacuum-assisted device can eliminate symp-
toms in patients presenting with abnormal nipple discharge.
Materials and Methods: Between March 2004 and October 2006, 36 patients
who presented with abnormal nipple discharge, underwent US-guided, 11-gauge
vacuum-assisted biopsy for a benign intraductal single mass on US. The ability of
the procedure to eliminate nipple discharge was evaluated by physical examina-
tion during follow-up US. Lesion characteristics, biopsy variables, and histologic
features were analyzed to identify factors affecting symptom resolution.
Results: Of the 36 lesions, 25 (69%) were intraductal papillomas, 10 (28%)
were fibrocystic changes, and one (3%) was a fibroadenoma. The nipple dis-
charge disappeared in 69% (25 of 36) of the women at a mean follow-up time of
25 months (range 12-42 month). There was no difference in the lesion character-
istics, biopsy variables, and the histologic features between groups that eliminat-
ed the symptom compared those with persistent nipple discharge.
Conclusion: US-guided directional vacuum-assisted removal of an intraductal
mass appears to eliminate nipple discharge in only 69% of patients and thus, it
should not be considered as an alternative to surgical excision.
bnormal nipple discharge is defined as unilateral, single-pore, sponta-
neous discharge. The standard treatment for abnormal nipple discharge is
surgical excision, which has been reduced from a complete mastectomy
to a single duct excision, because it is known that 80-90% of nipple discharge cases
are caused by benign diseases (e.g., benign papilloma, fibrocystic change, or ductecta-
sia), and that only 10-15% of cases are caused by breast carcinomas (1, 2).
The identification and localization of the cause of nipple discharge is the key to
successful treatment (3). Although a galactography has been preferentially used for the
identification and localization of the cause of nipple discharge, recent advances in
high-resolution breast ultrasonography (US) or MR galactography allow retro-areolar
ducts and small solid masses within these ducts to be clearly demonstrated (4). Several
researchers have reported that performing an US to detect intraductal abnormalities in
patients with an abnormal nipple discharge is comparable to that of a galactography,
and further, have suggested that US can be used to complement or alternative to a
galactography (5, 6).
During the last decade, percutaneous image-guided needle biopsies have allowed for
correct diagnosis of breast lesions. Moreover, the removal of lesions by an image-
guided directional vacuum-assisted biopsy has been found to reduce sampling errors,
radiologic-histological discordances, rebiopsies, and histologic underestimations, which
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Aare the main limitations of percutaneous needle biopsies
(7, 8). Furthermore, the incidental treatment of nipple
discharge during US-guided directional vacuum-assisted
removal (US-DVAR) has been reported to have success
rates ranging from 95 to 97% (9-11). However, these
studies only included intraductal papillomas (10) and have
lacked long-term follow-up information (11). Relatively
few studies have addressed the possibility of using US-
guided vacuum-assisted removal for symptom elimination
in patients presenting with abnormal nipple discharge.
Thus, the purpose of this study was to evaluate whether
the removal of an intraductal mass using an US-guided
vacuum-assisted device can eliminate the symptoms in
patients presenting with abnormal nipple discharge.
MATERIALS AND METHODS
Patients and Lesions
This retrospective review of images and medical records
was approved by the our Institutional Review Board.
Between March 2004 and October 2006, a search of
medical records revealed 145 consecutive patients present-
ing with abnormal nipple discharge. All patients underwent
a mammography and US to evaluate the cause of nipple
discharge, which was an initial work-up protocol at our
institution. Suspicious abnormalities were found in 95
patients. Among these patients, US-guided vacuum-assisted
removal was performed in 50 patients with an intraductal
mass revealed by US. Patients with abnormal nipple
discharge and an intraductal mass by US that subsequently
underwent surgery due to biopsy results of atypia (n = 6) or
malignancy (n = 2), and those without follow-up data (n =
4) or a follow-up examination less than 12 months after the
treatment (n = 2) were excluded from the study. The 36
remaining patients (age range, 18-80 years; mean age, 46
years) with serous (23 of 36, 64%) or bloody (13 of 36,
36%) nipple discharge constituted the study population. 
A mammography was performed in all 36 patients.
Twenty (56%) patients had a negative finding, four (11%)
had a mass, two (6%) had microcalcifications, one (3%)
had a mass with microcalcifications, and nine (25%) had a
focal asymmetry. No patient underwent a galactography. 
US Evaluation and US-Guided Directional Vacuum-
Assisted Removal (US-DVAR)
US examinations were performed by one of eleven
radiologists who specialized in breast imaging using a high-
resolution sonographic unit equipped with a 10- or 12-
MHz linear transducer (Voluson 730, Kretz, Austria; HDI
5000, Advanced Technology Laboratories, Bothell, WA).
Patients were placed in the supine or supine-oblique
position before undergoing the US. Radial and antiradial
US scans were performed by tracing the discharging duct,
lactiferous duct, and trigger points to identify and localize
the cause of the nipple discharge.
US-DVAR was performed using an 11-gauge vacuum-
assisted device (Mammotome; Ethicon-Endosurgery,
Cincinnati, OH) under the guidance of a high-resolution
sonographic unit with the 10- or 12-MHz linear transduc-
ers mentioned above. The patient’s skin was sterilized and
about 10-15 mL of 1% lidocaine hydrochloride was
injected into the skin, subcutaneous fat, and tissues around
the dilated duct. A 4-mm skin incision was then made with
a scalpel. Next, a probe was inserted either through or
directly subjacent to the lesion and then manually rotated
to sample both the target lesion and adjacent tissues in a
clockwise manner. We attempted to remove all evidence
of target lesions under continuous US monitoring. The
mean number of core samples obtained was 9.3 (range: 4-
22). Pre- and post-biopsy US images were obtained for all
lesions. The entire procedure took approximately 20-30
minutes. Fourteen (39%) procedures were performed by
one of three attending radiologists with 2-8 years of breast
imaging and intervention experience, 22 (61%) procedures
were performed by one of eight fellows who conducted
their first 5 to 10 biopsies under the supervision of an
attending radiologist.
Postprocedural Management Protocol
Pathology results were compared with relevant imaging
findings to determine concordances and discordances of
the biopsy results. Patients with a biopsy finding indicating
a malignancy or of a high-risk lesion underwent a surgical
excision. If the lesion had a highly suspicious sonographic
finding, a surgical excision was recommended, despite a
benign pathologic result. If the imaging findings were
determined to be concordant with a benign pathology, six,
12 and 24 month follow-ups were recommended.
The presence of nipple discharge or a residual lesion,
such as solid nodules, were evaluated by follow-up US and
clinical records.
Data Collection and Analysis
Radiologists who performed the procedures recorded the
lesion size (maximal diameter on US), lesion location, final
assessment category according to the Breast Imaging
Reporting and Data System (BI-RADS) (12), and the
number of core samples taken during the procedure. The
presence of abnormal nipple discharge as well as visible
residual lesion were recorded on US examination reports
during follow-up US.
Symptom elimination was defined as the absence of nipple
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evaluated whether symptom elimination was affected by
lesion variables (lesion size, location including distance from
the nipple, and BI-RADS category), biopsy variables
(number of core samples, radiologist experience), the
presence of a residual lesion by follow-up US, and histologic
findings. The χ
2 test, Fisher’s exact test, and the Student’s t-
test were performed using SPSS version 12.0 for Windows
(SPSS Inc., Chicago, IL), and results were deemed statisti-
cally significant at a two-sided significance level of 5%.
RESULTS
Of the 36 lesions, 69% (25 of 36) were intraductal
papillomas, 28% (10 of 36) were attributed to fibrocystic
change, whereas 3% (1 of 36) was a fibroadenoma based
on the US-DVAR histology. Subsequent surgical excision
was performed in nine patients (mean 8.1 ± 7.2 months
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Table 1. Comparison of US-Guided Directional Vacuum-Assisted Removal Results with Surgical Excision
Histologic Findings at Excision
Histologic Findings at Core Biopsy Fibrocystic Change  Intraductal Papilloma  Atypical Papilloma 
Follow-up 
(n = 1) (n = 5) (n = 3)
(n = 27)
Fibrocystic change (n = 10)    1 1 2* 06
Papilloma (n = 25)    0 4 1
� 20
Fibroadenoma (n = 1)    0 0 0 01
Note.─ * Surgical excision due to imaging-histologic discordance revealed atypical papilloma in one of two patients.
� Surgical excision due to increase in size of another solid nodule revealed atypical papilloma seven months later.
AB
Fig. 1. 44-year-old woman successfully treated for bloody nipple
discharge by US-guided directional vacuum-assisted removal.
A. Sonogram showing well-defined, intraductal single mass
(arrowhead) within dilated duct (arrows).
B. Sonogram showing directional vacuum-assisted probe (arrow)
underneath lesion.
C. Sonogram obtained immediately after US-guided directional
vacuum-assisted removal revealing mild fluid collection within
dilated duct (arrow). Mass was confirmed to be intraductal
papilloma. No residual nipple discharge was apparent at six month
follow-up.
Cafter US-DVAR, range 1-21 months) due to persistent or
recurrent nipple discharge (n = 7, 78%), radiologic-
pathologic discordance (n = 1, 11%) without nipple
discharge, or an increase in the size of another solid nodule
(n = 1, 11%). The target surgical excision sites were
assessed by follow-up US. Skin marking for the target
lesion was performed in eight patients.
The remaining 27 patients underwent a follow-up US.
No malignancy was found in either the nine patients who
underwent surgical excision or the 27 who underwent a
follow-up US (Table 1). 
US-DVAR eliminated the nipple discharge in 69% (25 of
36) of the patients (Fig. 1), the other 31% (11 of 36)
remained symptomatic (Fig. 2). The mean follow-up
duration was 25 months (range, 12-42). One (4%, 1 of 27)
patient underwent a final follow-up at 12 months, nine
patients (33%, 9 of 27) at 13-24 months, and 17 patients
(63%, 17 of 27) at 25-42 months. At the initial visits after
US-DVAR, nipple discharge had disappeared in 81% (29
of 36) of patients. However, four of these 29 later experi-
enced symptom recurrence (2 at 6 to 12 months and 2 at
19 months; 3 intraductal papillomas and 1 fibrocystic
change, by surgical excision).
The characteristics of groups with eliminated and persis-
tent nipple discharge are summarized in Table 2. Mean
lesion sizes were 1.0 cm and 1.0 cm (p = 0.649), whereas
the mean lesion distances from the nipple were 1.0 cm and
1.1 cm, respectively (p = 0.393). No difference was
observed between these two groups in terms of BI-RADS
category (p = 1.000) the number of core samples (p =
0.101), radiologist experience (i.e., attending radiologists
versus fellows) (p = 0.467), the presence of a residual
lesion on follow-up US (p = 0.328), and histologic results
by US-DVAR (p = 0.792). Of the four lesions with
Chang et al.
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AB
Fig. 2. 48-year-old woman with remaining bloody nipple discharge
symptom after US-guided directional vacuum-assisted removal.
A. Sonogram showing well-defined, single intraductal mass
(arrowhead) within dilated duct (arrow).
B. Sonogram obtained immediately after US-guided directional
vacuum-assisted removal revealing mild fluid collection within
slightly dilated duct (arrow). Mass was confirmed as intraductal
papilloma. 
C. Follow-up sonogram six months after US-guided directional
vacuum-assisted removal showing low echoic mass (arrow) in
subareolar area. Nipple discharge persisted and biopsy revealed
recurrent intraductal papilloma.
Cfibrocystic change that underwent surgical excision, one
benign papilloma, two atypical papillomas, and one
fibrocystic change were revealed (Table 1). Of the six
lesions that showed a fibrocystic change and the one
fibroadenoma, which was not excised, no case showed a
persisting symptom or symptom recurrence over a mean
follow-up of 31 months (range 23-42).
DISCUSSION
Of the 36 patients with abnormal nipple discharge, US-
DVAR eliminated nipple discharge in 25 (69%) at a mean
follow up of 25 months. At the six month follow-ups, nipple
discharge was absent in 29 of the 36 (81%). However, four
of the 36 (11%) developed the symptom later, and three of
these four patients were found to have intraductal
papilloma at surgery. Considering the 95-97% resolution
rate reported in previous studies (10, 11), the rate found in
the present study is poorer than expected. There are some
possible causes for the lower outcome of this study. First,
the key to eliminating nipple discharge is to correctly
identify and remove the cause, and in the present study,
target lesions within dilated ducts were traced to discharg-
ing nipple ducts by radial and antiradial US alone.
However, as described by Rissanen et al. (13), a certain
number of lesions invisible to US, are visualized with a
galactography. Furthermore, Dennis et al. (10) evaluated
symptom causes by repeated ductographic US correlation,
and found that this improved correct target lesion identifi-
cation. In addition, US has been shown to be limited in
terms of the detection of small intraductal lesions in periph-
eral ducts, especially when they are located at 3 cm or more
from the nipple (13, 14). Second, although we attempted to
remove all evidence of intraductal lesions by US-DVAR in
patients that presented with discharge, there was a substan-
tial probability of residual lesion not visible during
procedure (8), which might cause recurring symptoms later.
In our study, a follow-up US revealed residual lesions near
the DVAR site in 30% of patients with recurrent or persis-
tent symptoms. Furthermore, US-DVAR was performed in
the present study by one of eight fellows or three attending
radiologists, and symptom recurrence was slightly lower in
the group performed by the attending radiologists
compared to the fellows (3 of 14 [21%] versus 8 of 22
[36%]; p = 0.467), although the difference was not statisti-
cally significant. Variability of their experience could have
affected the lower resolution rate of US-DVAR.
In the present study, we also evaluated the factors affect-
ing symptom resolution to identify a subset of patients that
could be applied to the US-DVAR. However, lesion size,
location, BI-RADS category, number of core samples, and
the presence of a residual lesion by follow-up US were
found to be unrelated to symptom resolution. 
In terms of histologic findings, 69% (25 of 36) of the
US-Guided Vacuum-Assisted Benign Intraductal Mass Removal in Abnormal Nipple Discharge
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Table 2. Characteristics of Groups with Eliminated or Persistent Nipple Discharge Symptoms Following US-Guided Directional
Vacuum-Assisted Removal of Benign Intraductal Single Mass
Characteristics  Symptom Eliminated (n = 25) Symptom Persistent (n = 11) P value
Mean lesion size ± SD (cm) 1.0 ± 0.6  1.0 ± 0.6 0.649
Mean distance from duct orifice ± SD (cm) 1.0 ± 1.5 1.1 ± 1.3 0.393
BI-RADS category 1.000
Category 3 3 1
Category 4 22 10
4a 21 10
4b  1 0
4c 0 0
Mean number of core samples ± SD 8.9 ± 3.3  10.0 ± 5.1  0.101 
Residual lesion on follow-up US 0.328
Negative 22 (88%) 7 (70%)
Positive  03 (12%) 3 (30%)
Histologic finding at US-DVAR 0.792
Fibrocystic change 073
Papilloma 17 7
Fibroadenoma 010
Performing Radiologist
Attending Radiologists 11 3 0.467
Fellows 14 8
Note.─ SD = standard deviation, BI-RADS = Breast Imaging Reporting and Data System, US-DVAR = US-guided directional vacuum-assisted removal lesions were papillomas, and the other 31% were fibrocys-
tic change (n = 10) or fibroadenomas (n = 1). Of the four
cases of fibrocystic change with the remaining symptom,
surgical excision revealed one benign papilloma and two
atypical papillomas where the cause of discharge might
have not been accurately targeted during US-DVAR.
However, earlier researches reported that 20% of nipple
discharge cases were caused by fibrocystic changes or
ductectasia (11, 13), and often appeared as intraductal
echogenic lesions on US. In the present study, six cases
with fibrocystic changes and one case with fibroadenomas
in whom symptoms did not recur at the mean follow-up
period of 31 months (range 23-42), were considered to
have been accurately targeted during US-DVAR.
In terms of the diagnostic accuracy of US-DVAR, no
malignant lesion was found among the nine lesions treated
surgically or among the 27 lesions followed-up. The five
lesions with papilloma at biopsy histology were found to
be benign papillomas in four cases and atypical papilloma
in one case at surgery. Recent studies have concluded that
benign papillomas detected by core needle biopsy should
be surgically excised, because 21-31% of the benign
papillary lesions were upgraded to high-risk lesions or
cancer at surgery (15, 16). However, it remains to be
determined whether an US-DVAR diagnosis of benign
papilloma can obviate the need for surgical excision, which
is beyond the scope of this study. 
The present study has some limitations. First, we did not
perform a consecutive case collection and include all
symptomatic patients. Second, the sample size is small.
Third, follow-up period is not long enough to evaluate
recurring symptoms or establish the benignity. We
included only patients with more than 12-month follow-up
in the study. However, to confirm the benignity of the
lesion, a 24-month follow-up is required. Fourth, we did
not perform galactography to identify the cause of
abnormal nipple discharge. Small peripheral intraductal
lesions, which are not visible on US, may cause residual
symptoms. To establish the management of nipple
discharge with intraductal solitary lesions on US, the
proper selection of pure intraductal lesions based on
galactography and prospective large group study results
comparing surgical excision and vacuum-assisted removal
of intraductal lesions would be needed. 
To conclude, US-guided directional vacuum-assisted
removal of a benign intraductal mass eliminated nipple
discharge in only 69% of patients and thus, this modality
should not be considered as an alternative to surgical
excision.
References
1. Paterok EM, Rosenthal H, Sa ¨ bel M. Nipple discharge and
abnormal galactogram. Results of a long-term study (1964-
1990). Eur J Obstet Gynecol Reprod Biol 1993;50:227-234
2. Leis HP Jr. Management of nipple discharge. World J Surg
1989;13:736-742
3. Al Sarakbi W, Worku D, Escobar PF, Mokbel K. Breast papillo-
mas: current management with a focus on a new diagnostic and
therapeutic modality. Int Semin Surg Oncol 2006;3:1
4. Yu ¨ cesoy C, Oztu ¨ rk E, Ozer Y, Edgu ¨er T, Hekimoglu B.
Conventional galactography and MR contrast galactography for
diagnosing nipple discharge: preliminary results. Korean J
Radiol 2008;9:426-431
5. Cho N, Oh KK, Nam JE. Solitary breast papilloma: comparison
of galactographic and ductal echographic features. J Korean Soc
Med Ultrasound 2001;20:315-320
6. Han BK, Choe YH, Ko YH, Yang JH, Nam SJ. Benign papillary
lesions of the breast: sonographic-pathologic correlation. J
Ultrasound Med 1999;18:217-223
7. Liberman L, Kaplan JB, Morris EA, Abramson AF, Menell JH,
Dershaw DD. To excise or to sample the mammographic target:
what is the goal of stereotactic 11-gauge vacuum-assisted breast
biopsy? AJR Am J Roentgenol 2002;179:679-683
8. March DE, Coughlin BF, Barham RB, Goulart RA, Klein SV,
Bur ME, et al. Breast masses: removal of all US evidence during
biopsy by using a handheld vacuum-assisted device--initial
experience. Radiology 2003;227:549-555
9. Liberman L, Bracero N, Vuolo MA, Dershaw DD, Morris EA,
Abramson AF, et al. Percutaneous large-core biopsy of papillary
breast lesions. AJR Am J Roentgenol 1999;172:331-337
10. Dennis MA, Parker S, Kaske TI, Stavros AT, Camp J. Incidental
treatment of nipple discharge caused by benign intraductal
papilloma through diagnostic Mammotome biopsy. AJR Am J
Roentgenol 2000;174:1263-1268
11. Govindarajulu S, Narreddy SR, Shere MH, Ibrahim NB, Sahu
AK, Cawthorn SJ. Sonographically guided mammotome
excision of ducts in the diagnosis and management of single duct
nipple discharge. Eur J Surg Oncol 2006;32:725-728
12. American College of Radiology. Breast imaging reporting and
data system (BI-RADSTM) - Ultrasound. Reston, Va. American
College of Radiology, 2003
13. Rissanen T, Reinikainen H, Apaja-Sarkkinen M. Breast sonogra-
phy in localizing the cause of nipple discharge: comparison with
galactography in 52 patients. J Ultrasound Med 2007;26:1031-
1039
14. Lam WW, Chu WC, Tang AP, Tse G, Ma TK. Role of radiologic
features in the management of papillary lesions of the breast.
AJR Am J Roentgenol 2006;186:1322-1327
15. Liberman L, Tornos C, Huzjan R, Bartella L, Morris EA,
Dershaw DD. Is surgical excision warranted after benign,
concordant diagnosis of papilloma at percutaneous breast
biopsy? AJR Am J Roentgenol 2006;186:1328-1334
16. Mercado CL, Hamele-Bena D, Oken SM, Singer CI, Cangiarella
J. Papillary lesions of the breast at percutaneous core-needle
biopsy. Radiology 2006;238:801-808
Chang et al.
580 Korean J Radiol 10(6), Nov/Dec 2009